Martina Spaziante

Martina Spaziante

Auto-generated profile, based on publicly available information

Martina Spaziante

Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Rome, Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Manuela Di FrancoManuela Di Franco
Manuela Di Franco
BLbruno lucchino
bruno lucchino
MSMartina Spaziante
Martina Spaziante
CICristina Iannuccelli
Cristina Iannuccelli
GVGuido Valesini
Guido Valesini
GIGiancarlo Iaiani
Giancarlo Iaiani
Systemic rheumatic diseases have significant morbidity and mortality, due in large part to concurrent infections. The lung has been reported among the most frequent sites of infection in patients with rheumatic disease, who are susceptible to developing pneumonia sustained both by common pathogens and by opportunistic microorganisms. Patients with rheumatic disease show a peculiar vulnerability to infectious complications. This is due in part to intrinsic disease-related immune dysregulation and in part to the immunosuppressive treatments. Several therapeutic agents have been associated to a wide spectrum of infections, complicating the management of rheumatic diseases. This review discusses the most frequent pulmonary infections encountered in rheumatic diseases, focusing on opportunistic agents, consequent diagnostic challenges and appropriate therapeutic strategies.

31 December 2019 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
SVSerena Vita
Serena Vita
MSMaria Teresa Sinopoli
Maria Teresa Sinopoli
LSLucia Fontanelli Sulekova
Lucia Fontanelli Sulekova
LMLuca Morucci
Luca Morucci
MLMaurizio Lopalco
Maurizio Lopalco
Giancarlo CeccarelliGiancarlo Ceccarelli
Giancarlo Ceccarelli
Introduction: Control of vaccine preventable diseases, while constituting a priority of European health policies, is challenged by migrations from countries with suboptimal levels of immunization coverage. We report here two different types of vaccination campaign strategy in one of the bigger Italian asylum seekers’ centres. The vaccination service staff of the local national health institute came monthly during the first three years of observation, while in the last year, the vaccinations were offered directly upon arrival of migrants in the asylum seekers’ centre. Methodology: we performed a descriptive cross-sectional study that analysed data collected from the database of the internal healthcare facility and ARVA Target tool, regarding vaccinations performed from 2013 to 2017 in the asylum seekers’ centre. Results: In the four years of observation period the asylum seekers centre hosted 3941 migrants. Among them, 85% were vaccinated during their stay, for a total of 4252 vaccinations administered, covering 95% of minors and 85% of adults. During the study period, there was an important increase from an average of 10.5% of migrants vaccinated in the first three years to 66% in the last year, when vaccines were delivered directly upon arrival in the centre. Conclusions: To improve the rate of immunization in migrants, the first requirement is a strong collaboration with the local vaccine services and the second,vaccinations must be carried out when migrants arrive at the asylum seekers’ centre, avoiding any delay.

1 May 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
MSMartina Spaziante
Martina Spaziante
SGSimone Giuliano
Simone Giuliano
Giancarlo CeccarelliGiancarlo Ceccarelli
Giancarlo Ceccarelli
Francesco AlessandriFrancesco Alessandri
Francesco Alessandri
CBCristian Borrazzo
Cristian Borrazzo
MVMario Venditti
Mario Venditti
Data on septic thrombosis caused by Gram-negative bacilli (GN-ST) in intensive care unit (ICU) patients are currently limited. The aim of this retrospective case-control study (matched 1:3) performed over a 15-month period on ICU patients with bacteraemia, associated (cases) or not (controls) with GN-ST, was to assess 30-day mortality and clinical/microbiological features of GN-ST. During the study period, 16 patients with GN-ST and 48 controls were analyzed. Polytrauma was the cause of ICU admission in 12 (75%) cases and 22 (46%) controls (p = 0.019). In no case of septic thrombosis was surgical debridement performed. The site of venous thrombosis was more frequently in the lower limbs, associated with bone fracture in nine out of 12 (75%) cases. The median duration of bacteraemia (22 days vs 1 day; p < 0.001) and time to clinical improvement (15 days vs 4 days; p < 0.001) were significantly longer in cases than in controls. On analysis of the receiver operating characteristics (ROC) curve, bacteraemia >72 h was significantly associated with GN-ST (area under the curve (AUC) 0.95, sensitivity 0.996 and specificity 0.810; p < 0.001). Finally, 30-day mortality was 20% in cases and 67% in controls (p < 0.001). Critically ill patients with GN-ST showed specific clinical features. Despite delayed bacteraemia clearance, targeted antibiotic therapy plus anticoagulation usually provided clinical improvement and a low 30-day mortality rate.